Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis - Related Studies

Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis

This study has been terminated.

Study NCT00000430. Last updated on January 2, 2007. Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Osteopenia
		Osteoporosis

2	Additional conditions recognized in this trial
		Bone Diseases, Metabolic

3	More general conditions related to this trial
		Bone Diseases
		Musculoskeletal Diseases

4	Interventions listed in this trial
		Alendronate
		Estrogen/progestin therapy

5	More general drug interventions related to this trial
		Bone Density Conservation Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)